Julie Fleshman։ Advocating for Continued Federal Investment in Pancreatic Cancer Research
Julie Fleshman։ Advocating for Continued Federal Investment in Pancreatic Cancer Research oncodaily.com
Онкология
🎗️Лента новостей
Онкология
Losing Weight and Breast Cancer Risk? The GLP-1 Question
Losing Weight and Breast Cancer Risk? The GLP-1 Question The ASCO Post
🎗️
Онкология
Cancer centers continue to face recurring drug shortages, NCCN survey finds
Cancer centers continue to face recurring drug shortages, NCCN survey finds The Cancer Letter
Онкология
McAllen Cancer Survivor Takes Her Fight for Patients to Washington
McAllen Cancer Survivor Takes Her Fight for Patients to Washington Texas Border Business
Онкология
McAllen Cancer Survivor Takes Her Fight for Patients to Washington
McAllen Cancer Survivor Takes Her Fight for Patients to Washington Mega Doctor News
Онкология
Imène Hadji at COGC 2026: What It Takes to Make Cancer Care Truly Accessible for Every Patient
Imène Hadji at COGC 2026: What It Takes to Make Cancer Care Truly Accessible for Every Patient oncodaily.com
Онкология
BICEPS Grants Advance Engineering Innovations in Cancer Care and Early Detection
BICEPS Grants Advance Engineering Innovations in Cancer Care and Early Detection University of Utah Health
Онкология
After Early Ovarian Cancer Diagnosis, Woman Finds Relief From Chemotherapy-Related Nerve Pain
After Early Ovarian Cancer Diagnosis, Woman Finds Relief From Chemotherapy-Related Nerve Pain Cleveland Clinic
Онкология
Nazik Hammad: Award Celebrates Efforts to Improve Cancer Outcomes in Africa
Nazik Hammad: Award Celebrates Efforts to Improve Cancer Outcomes in Africa Oncodaily
Онкология
What Are the Illness-Related Experiences of Male Patients With Breast Cancer?
What Are the Illness-Related Experiences of Male Patients With Breast Cancer? Cancer Nursing Today
🎗️
Онкология
FES-PET guides second-line therapy decisions in breast cancer
FES-PET guides second-line therapy decisions in breast cancer AuntMinnie
Онкология
FDA approves combo therapy for breast cancer
The FDA approved combination imlunestrant plus abemaciclib for adults with hormone therapy-resistant estrogen receptor-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer. The combination therapy (Inluriyo and Verzenio, Eli Lilly & Co.) was approved with the indication for certain patients with…
/https%3A%2F%2Fs3.eu-central-1.amazonaws.com%2Fmedia.my.ua%2Ffeed%2F46%2F54163b142c1b308d6079b44bcba60353.jpg)
Онкология
Что поможет снизить риск рецидива рака и смерти: исследователи ошеломили открытием
Что поможет снизить риск рецидива рака и смерти: исследователи ошеломили открытием my.ua
Онкология
Richard Sassun Shares New Research on Recurrent Ovarian Cancer Treatment
Richard Sassun Shares New Research on Recurrent Ovarian Cancer Treatment Oncodaily
Онкология
Variety of Yale Cancer Center Research Highlights to be Presented at Radiation and Oncology Conference
Variety of Yale Cancer Center Research Highlights to be Presented at Radiation and Oncology Conference Yale School of Medicine